Fri, September 11, 2020
Thu, September 10, 2020
Wed, September 9, 2020

Matthew Harrison Initiated (AKRO) at Buy and Held Target at $70 on, Sep 10th, 2020

Matthew Harrison of Morgan Stanley, Initiated "Akero Therapeutics, Inc." (AKRO) at Buy and Held Target at $70 on, Sep 10th, 2020.

Matthew has made no other calls on AKRO in the last 4 months.



There are 2 other peers that have a rating on AKRO. Out of the 2 peers that are also analyzing AKRO, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $62 on, Monday, July 20th, 2020
  • Michael Morabito of "Chardan Capital" Initiated at Strong Buy and Held Target at $79 on, Tuesday, July 7th, 2020